SEASTAR MEDICAL HOLDING CORP (ICU) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ICU • US81256L3024

2.55 USD
-0.02 (-0.78%)
Last: Feb 5, 2026, 12:54 PM
Fundamental Rating

3

ICU gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. ICU has a great financial health rating, but its profitability evaluates not so good. ICU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ICU had negative earnings in the past year.
  • ICU had a negative operating cash flow in the past year.
  • In the past 5 years ICU always reported negative net income.
  • ICU had a negative operating cash flow in each of the past 5 years.
ICU Yearly Net Income VS EBIT VS OCF VS FCFICU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • The Return On Assets of ICU (-87.99%) is worse than 75.27% of its industry peers.
  • ICU's Return On Equity of -119.20% is on the low side compared to the rest of the industry. ICU is outperformed by 63.98% of its industry peers.
Industry RankSector Rank
ROA -87.99%
ROE -119.2%
ROIC N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICU Yearly ROA, ROE, ROICICU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

  • ICU's Gross Margin of 95.35% is amongst the best of the industry. ICU outperforms 99.46% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ICU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICU Yearly Profit, Operating, Gross MarginsICU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ICU has more shares outstanding
  • Compared to 1 year ago, ICU has an improved debt to assets ratio.
ICU Yearly Shares OutstandingICU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ICU Yearly Total Debt VS Total AssetsICU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • ICU has an Altman-Z score of -1.81. This is a bad value and indicates that ICU is not financially healthy and even has some risk of bankruptcy.
  • ICU has a Altman-Z score (-1.81) which is in line with its industry peers.
  • ICU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.81
ROIC/WACCN/A
WACCN/A
ICU Yearly LT Debt VS Equity VS FCFICU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

  • A Current Ratio of 3.66 indicates that ICU has no problem at all paying its short term obligations.
  • The Current ratio of ICU (3.66) is better than 63.98% of its industry peers.
  • A Quick Ratio of 3.64 indicates that ICU has no problem at all paying its short term obligations.
  • ICU has a better Quick ratio (3.64) than 73.12% of its industry peers.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.64
ICU Yearly Current Assets VS Current LiabilitesICU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ICU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.15%, which is quite impressive.
  • Looking at the last year, ICU shows a very strong growth in Revenue. The Revenue has grown by 1195.59%.
EPS 1Y (TTM)32.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)1195.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%

3.2 Future

  • Based on estimates for the next years, ICU will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.88% on average per year.
  • ICU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 147.47% yearly.
EPS Next Y20.49%
EPS Next 2Y25.6%
EPS Next 3Y18.88%
EPS Next 5YN/A
Revenue Next Year601.24%
Revenue Next 2Y229.67%
Revenue Next 3Y147.47%
Revenue Next 5YN/A

3.3 Evolution

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 1M 2M 3M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -50 -100 -150 -200 -250

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ICU. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICU Price Earnings VS Forward Price EarningsICU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICU Per share dataICU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ICU's earnings are expected to grow with 18.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.6%
EPS Next 3Y18.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ICU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (2/5/2026, 12:54:45 PM)

2.55

-0.02 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners3.03%
Inst Owner Change2.08%
Ins Owners0.75%
Ins Owner Change0.36%
Market Cap91.93M
Revenue(TTM)881.00K
Net Income(TTM)-13.66M
Analysts80
Price Target10.2 (300%)
Short Float %N/A
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.37%
Min EPS beat(2)14.19%
Max EPS beat(2)58.55%
EPS beat(4)3
Avg EPS beat(4)22.21%
Min EPS beat(4)-0.12%
Max EPS beat(4)58.55%
EPS beat(8)5
Avg EPS beat(8)3.4%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)19.9%
Min Revenue beat(2)-27.52%
Max Revenue beat(2)67.33%
Revenue beat(4)2
Avg Revenue beat(4)19.36%
Min Revenue beat(4)-55.78%
Max Revenue beat(4)93.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)900%
PT rev (3m)400%
EPS NQ rev (1m)-840.91%
EPS NQ rev (3m)-696.15%
EPS NY rev (1m)-872.22%
EPS NY rev (3m)-750.69%
Revenue NQ rev (1m)52.04%
Revenue NQ rev (3m)6.43%
Revenue NY rev (1m)44.43%
Revenue NY rev (3m)24.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 104.34
P/FCF N/A
P/OCF N/A
P/B 8.02
P/tB 8.02
EV/EBITDA N/A
EPS(TTM)-8.4
EYN/A
EPS(NY)-3.29
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.02
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.99%
ROE -119.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.35%
FCFM N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.66
Quick Ratio 3.64
Altman-Z -1.81
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y20.49%
EPS Next 2Y25.6%
EPS Next 3Y18.88%
EPS Next 5YN/A
Revenue 1Y (TTM)1195.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%
Revenue Next Year601.24%
Revenue Next 2Y229.67%
Revenue Next 3Y147.47%
Revenue Next 5YN/A
EBIT growth 1Y13.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.91%
OCF growth 3YN/A
OCF growth 5YN/A

SEASTAR MEDICAL HOLDING CORP / ICU FAQ

Can you provide the ChartMill fundamental rating for SEASTAR MEDICAL HOLDING CORP?

ChartMill assigns a fundamental rating of 3 / 10 to ICU.


What is the valuation status for ICU stock?

ChartMill assigns a valuation rating of 0 / 10 to SEASTAR MEDICAL HOLDING CORP (ICU). This can be considered as Overvalued.


What is the profitability of ICU stock?

SEASTAR MEDICAL HOLDING CORP (ICU) has a profitability rating of 1 / 10.


What is the expected EPS growth for SEASTAR MEDICAL HOLDING CORP (ICU) stock?

The Earnings per Share (EPS) of SEASTAR MEDICAL HOLDING CORP (ICU) is expected to grow by 20.49% in the next year.